GB1325797A
(en)
|
1970-09-24 |
1973-08-08 |
Upjohn Co |
Medicines comprising cytidine derivatives
|
GB1386334A
(en)
|
1972-09-22 |
1975-03-05 |
Kohjin Co |
2,2-cyclocytidine derivatives
|
GB1480120A
(en)
|
1973-11-29 |
1977-07-20 |
Kohjin Co |
N4-substituted-2,2'-cyclocytidine derivatives
|
US4096324A
(en)
|
1975-07-07 |
1978-06-20 |
The Upjohn Company |
Cytidine nucleoside compound
|
US5736531A
(en)
|
1987-10-28 |
1998-04-07 |
Pro-Neuron, Inc. |
Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
|
US5470838A
(en)
|
1987-10-28 |
1995-11-28 |
Pro-Neuron, Inc. |
Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
|
WO1990015065A1
(en)
|
1989-06-05 |
1990-12-13 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides and methods for preparing the same
|
EP0558634A4
(en)
|
1990-11-23 |
1995-06-28 |
Gilead Sciences Inc |
Triplex-forming oligomers containing modified bases
|
RU2085557C1
(en)
|
1991-09-30 |
1997-07-27 |
Санкио Компани Лимитед |
Pyrimidine nucleoside derivatives or their pharmaceutically acceptable salts and method of their synthesis
|
ATE151432T1
(en)
|
1991-10-11 |
1997-04-15 |
Acad Of Science Czech Republic |
ANTIVIRAL ACYCLIC PHOSPHONOMETHOXYALKYL SUBSTITUTED, ALKENYL AND ALKYNYL PURINE AND PYRIMIDINE DERIVATIVES
|
JP3739785B2
(en)
|
1991-11-26 |
2006-01-25 |
アイシス ファーマシューティカルズ,インコーポレイティド |
Enhanced triple and double helix shaping using oligomers containing modified pyrimidines
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
IS2334B
(en)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl protease inhibitor of a new class of sulfonamides
|
EP0695306A1
(en)
|
1993-04-19 |
1996-02-07 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
US5349947A
(en)
|
1993-07-15 |
1994-09-27 |
Newhouse Michael T |
Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
|
WO1995007920A1
(en)
|
1993-09-17 |
1995-03-23 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
KR100386685B1
(en)
|
1993-09-17 |
2003-12-31 |
길리애드 사이언시즈, 인코포레이티드 |
Nucleotide Homolog
|
WO1996026933A1
(en)
|
1995-02-27 |
1996-09-06 |
Gilead Sciences, Inc. |
Novel selective inhibitors of viral or bacterial neuraminidases
|
US6043358A
(en)
|
1995-11-01 |
2000-03-28 |
Merck & Co., Inc. |
Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
|
CN1238762A
(en)
|
1996-10-21 |
1999-12-15 |
吉里德科学公司 |
Piperidine compounds
|
GB9718913D0
(en)
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
EP1294735A2
(en)
|
2000-05-26 |
2003-03-26 |
Novirio Pharmaceuticals Limited |
Methods and compositions for treating flaviviruses and pestiviruses
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
CA2743451A1
(en)
*
|
2000-10-18 |
2002-04-25 |
Pharmasset, Inc. |
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
KR101195019B1
(en)
|
2000-10-18 |
2012-10-29 |
파마셋 인코포레이티드 |
Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
|
US20030124512A1
(en)
|
2000-10-18 |
2003-07-03 |
Lieven Stuyver |
Simultaneous quantification of nucleic acids in diseased cells
|
SK287423B6
(en)
|
2001-04-30 |
2010-09-07 |
Trommsdorff Gmbh & Co. Kg Arzneimittel |
Pharmaceutically active uridine esters, the use of them, method for the preparation of said uridine esters and pharmaceutical composition
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US7049303B2
(en)
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
CN1656109A
(en)
|
2002-04-26 |
2005-08-17 |
吉里德科学公司 |
Non nucleoside reverse transcriptase inhibitors
|
US20050239054A1
(en)
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
ATE544453T1
(en)
|
2002-07-15 |
2012-02-15 |
Gilead Sciences Inc |
COMBINATION THERAPIES WITH L-FMAU FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS
|
AU2003264406A1
(en)
|
2002-09-11 |
2004-04-30 |
Michio Ishibashi |
Drug or cosmetic
|
US20040194155A1
(en)
|
2002-10-01 |
2004-09-30 |
Gilead Sciences, Inc. |
HBV mutations associated with reduced susceptibility to adefovir
|
US20040157804A1
(en)
|
2002-10-16 |
2004-08-12 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
AU2003287606A1
(en)
|
2002-11-12 |
2004-06-03 |
Enzon Pharmaceuticals, Inc. |
Novel acylating reagents
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
AU2003297612A1
(en)
|
2002-12-02 |
2004-06-23 |
Gilead Sciences, Inc. |
2-substituted-3-propenamide derivatives and methods of using the same
|
KR20090053867A
(en)
|
2003-01-14 |
2009-05-27 |
길리애드 사이언시즈, 인코포레이티드 |
Compositions and methods for combination antiviral therapy
|
WO2004096286A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
CN101410120A
(en)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
Anti-inflammatory phosphonate compounds
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
MXPA05011294A
(en)
|
2003-04-25 |
2006-03-15 |
Gilead Sciences Inc |
Anti-inflammatory phosphonate compounds.
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
AU2004260789B2
(en)
|
2003-07-30 |
2011-06-30 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
WO2005028478A1
(en)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
RU2264409C2
(en)
|
2003-10-01 |
2005-11-20 |
Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") |
2'-amino-2'-deoxynucleosides as inhibitors if measles and marburg virusus reproduction
|
EP1678321A1
(en)
|
2003-10-24 |
2006-07-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
EP1680435A1
(en)
|
2003-11-03 |
2006-07-19 |
Cognis IP Management GmbH |
Acyl ribonucleosides and acyl deoxyribonucleosides
|
WO2005063751A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
SG149067A1
(en)
|
2003-12-22 |
2009-01-29 |
Leuven K U Res & Dev |
IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
|
WO2005066189A1
(en)
|
2003-12-30 |
2005-07-21 |
Gilead Sciences, Inc. |
Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
|
WO2005070901A2
(en)
|
2004-01-12 |
2005-08-04 |
Gilead Sciences, Inc. |
Pyrimidyl phosphonate antiviral compounds and methods of use
|
JP2007518815A
(en)
|
2004-01-21 |
2007-07-12 |
ギリアード サイエンシーズ, インコーポレイテッド |
Use of adefovir or tenofovir to inhibit MMTV-like virus involved in breast cancer and primary biliary cirrhosis
|
JP2007532665A
(en)
|
2004-04-14 |
2007-11-15 |
ギリアード サイエンシーズ, インコーポレイテッド |
Phosphonate analogues of HIV integrase inhibitor compounds
|
UA93354C2
(en)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Topical antiviral formulations
|
JP5676839B2
(en)
|
2004-07-16 |
2015-02-25 |
ギリアード サイエンシーズ, インコーポレイテッド |
Antiviral compounds
|
JP5014129B2
(en)
|
2004-07-27 |
2012-08-29 |
ギリアード サイエンシーズ, インコーポレイテッド |
Imidazo [4,5-d] pyrimidines, their use and methods of preparation
|
ES2363160T3
(en)
|
2004-07-27 |
2011-07-22 |
Gilead Sciences, Inc. |
NUCELOSIDIC PHOSPHONATE CONJUGATES AS ANTI-HIV AGENTS.
|
DE102004051804A1
(en)
*
|
2004-10-21 |
2006-04-27 |
Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) |
Beta-L-N4-hydroxycytosine deoxynucleosides and their use as pharmaceutical agents for the prophylaxis or therapy of viral diseases
|
EP1809277A2
(en)
|
2004-10-26 |
2007-07-25 |
Inc. Gilead Sciences |
Phosphonate derivatives of mycophenolic acid
|
US20060252791A1
(en)
|
2004-12-21 |
2006-11-09 |
Gilead Sciences, Inc. |
Imidazo[4,5-c]pyridine compound and method of antiviral treatment
|
WO2006091905A1
(en)
|
2005-02-25 |
2006-08-31 |
Gilead Sciences, Inc. |
Bicyclo (3.1.0) hexane derivatives as antiviral compounds
|
AR057023A1
(en)
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
HETEROCICLICAL COMPOUNDS WITH HIV-INTEGRASA INHIBITING PROPERTIES
|
ES2569881T3
(en)
|
2005-06-08 |
2016-05-12 |
The University Of North Carolina At Chapel Hill |
Procedures to facilitate the survival of neuronal cells using peptide and non-peptide BDNF neurotrophin mimetics
|
TW200738742A
(en)
|
2005-07-14 |
2007-10-16 |
Gilead Sciences Inc |
Antiviral compounds
|
TWI389908B
(en)
|
2005-07-14 |
2013-03-21 |
Gilead Sciences Inc |
Antiviral compounds
|
WO2007014174A2
(en)
|
2005-07-25 |
2007-02-01 |
Gilead Sciences, Inc. |
Drug-resistant mutants of hepatitis c virus
|
CA2616314A1
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
BRPI0614578A2
(en)
|
2005-08-16 |
2011-04-05 |
Irm Llc |
compound, pharmaceutical composition as protein kinase inhibitors, as well as their method and use
|
JP4885963B2
(en)
|
2005-09-22 |
2012-02-29 |
エフ.ホフマン−ラ ロシュ アーゲー |
Selective O-acylation of nucleosides
|
SG170795A1
(en)
|
2005-12-30 |
2011-05-30 |
Gilead Sciences Inc |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
EA016140B1
(en)
|
2006-03-29 |
2012-02-28 |
Джилид Сайэнс, Инк. |
Process for preparing bisfuran alcohol
|
WO2008003149A2
(en)
|
2006-07-06 |
2008-01-10 |
Gilead Sciences , Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
TWI399377B
(en)
|
2006-07-07 |
2013-06-21 |
Gilead Sciences Inc |
Modulators of toll-like receptor 7
|
EP2049506B2
(en)
|
2006-07-07 |
2024-05-08 |
Gilead Sciences, Inc. |
Modulators of pharmacokinetic properties of therapeutics
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
DE602007004220D1
(en)
|
2006-07-07 |
2010-02-25 |
Leuven K U Res & Dev |
NEW PYRIDAZIN COMPOUND AND ITS USE
|
US8673929B2
(en)
|
2006-07-20 |
2014-03-18 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
WO2008009078A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
WO2008009079A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
Substituted pteridines useful for the treatment and prevention of viral infections
|
WO2008011116A2
(en)
|
2006-07-21 |
2008-01-24 |
Gilead Sciences, Inc. |
Aza-peptide protease inhibitors
|
US20090306112A1
(en)
|
2006-07-21 |
2009-12-10 |
Gilead Sciences, Inc. |
Antiviral protease inhibitors
|
US20090312318A1
(en)
|
2006-07-24 |
2009-12-17 |
Desai Manoj C |
Therapeutic compounds and methods
|
SG174016A1
(en)
|
2006-07-24 |
2011-09-29 |
Korea Res Inst Chem Tech |
Hiv reverse transcriptase inhibitors
|
EP2068912A2
(en)
|
2006-09-27 |
2009-06-17 |
Coley Pharmaceutical Group, Inc. |
Compositions of tlr ligands and antivirals
|
JP5639762B2
(en)
|
2006-12-14 |
2014-12-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
Virus inhibitor
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
WO2008077650A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
US8143394B2
(en)
|
2006-12-26 |
2012-03-27 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
US8324179B2
(en)
|
2007-02-09 |
2012-12-04 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
PT2487163T
(en)
|
2007-02-23 |
2016-11-21 |
Gilead Sciences Inc |
Modulators of pharmacokinetic properties of therapeutics
|
ATE540672T1
(en)
*
|
2007-03-29 |
2012-01-15 |
Hoffmann La Roche |
PHARMACEUTICAL COMPOSITION AND METHOD
|
US7968544B2
(en)
|
2007-06-29 |
2011-06-28 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
US8354421B2
(en)
|
2007-06-29 |
2013-01-15 |
Korea Research Insitute Of Chemical Technology |
HIV reverse transcriptase inhibitors
|
AU2008270630B2
(en)
|
2007-06-29 |
2014-01-16 |
Gilead Sciences, Inc. |
Therapeutic compositions and the use thereof
|
EA200971096A1
(en)
|
2007-06-29 |
2010-08-30 |
Джилид Сайэнс, Инк. |
THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION
|
MX2009013804A
(en)
|
2007-06-29 |
2010-02-03 |
Korea Res Inst Chem Tech |
Novel hiv reverse transcriptase inhibitors.
|
KR20100038417A
(en)
|
2007-06-29 |
2010-04-14 |
길리애드 사이언시즈, 인코포레이티드 |
Antiviral compounds
|
US20090047252A1
(en)
|
2007-06-29 |
2009-02-19 |
Gilead Sciences, Inc. |
Antiviral compounds
|
JP5465666B2
(en)
|
2007-06-29 |
2014-04-09 |
ギリアード サイエンシーズ, インコーポレイテッド |
Antiviral compounds
|
UA99466C2
(en)
|
2007-07-06 |
2012-08-27 |
Гилиад Сайенсиз, Инк. |
Crystalline pyridazine compound
|
WO2009058800A2
(en)
|
2007-10-29 |
2009-05-07 |
President And Fellows Of Harvard College |
Synthesis of nucleosides
|
JP2011508740A
(en)
|
2007-12-27 |
2011-03-17 |
エピファニー バイオサイエンシズ, インク. |
Antiviral compounds
|
PT2231628E
(en)
|
2008-01-04 |
2015-12-29 |
Gilead Sciences Inc |
Inhibitors of cytochrome p450
|
TWI444384B
(en)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
Nucleotide analogues and their use in the treatment of malignancies
|
BRPI0910455B8
(en)
|
2008-04-23 |
2021-05-25 |
Gilead Sciences Inc |
1'-substituted carba-nucleoside analogues for antiviral treatment and pharmaceutical composition comprising them
|
WO2009143011A1
(en)
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
US8536187B2
(en)
|
2008-07-03 |
2013-09-17 |
Gilead Sciences, Inc. |
2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
|
AU2009268681B2
(en)
|
2008-07-08 |
2014-10-02 |
Gilead Sciences, Inc. |
Salts of HIV inhibitor compounds
|
AR072534A1
(en)
|
2008-07-25 |
2010-09-01 |
Gilead Sciences Inc |
ANTIVIRAL COMPOUNDS
|
TW201639852A
(en)
|
2008-12-09 |
2016-11-16 |
吉李德科學股份有限公司 |
Intermediate compounds for preparation of compounds useful as modulators of toll-like receptors
|
UY32325A
(en)
|
2008-12-19 |
2010-07-30 |
Gilead Sciences Inc |
HCV NS3 PROTEASA INHIBITORS
|
UY32332A
(en)
|
2008-12-22 |
2010-07-30 |
Gilead Sciences Inc |
MACROCYCLIC COMPOUNDS ITS DRUGS, N-OXIDES, ADDITION SALTS, QUATERNARY AMINES, METAL COMPLEXES AND STEREOCHEMICALLY ISOMERIC PURE FORMS.
|
US8012942B2
(en)
|
2009-02-10 |
2011-09-06 |
Gilead Sciences, Inc. |
Carba-nucleoside analogs for antiviral treatment
|
DK2430014T3
(en)
|
2009-05-13 |
2015-11-30 |
Gilead Pharmasset Llc |
Anti-viral compounds
|
TWI598358B
(en)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
Nucleoside phosphoramidates
|
TW201105323A
(en)
|
2009-06-23 |
2011-02-16 |
Gilead Sciences Inc |
Pharmaceutical compositions useful for treating HCV
|
US20100323989A1
(en)
|
2009-06-23 |
2010-12-23 |
Gilead Sciences, Inc. |
Pharmaceutical combinations useful for treating hcv
|
TW201113279A
(en)
|
2009-06-23 |
2011-04-16 |
Gilead Sciences Inc |
Pharmaceutical compositions useful for treating HCV
|
WO2011005842A1
(en)
|
2009-07-09 |
2011-01-13 |
Gilead Sciences, Inc. |
Anti-rsv compounds
|
UY32793A
(en)
|
2009-07-21 |
2011-01-31 |
Gilead Sciences Inc |
INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS AND ITS USES
|
KR20120081123A
(en)
|
2009-09-09 |
2012-07-18 |
길리애드 사이언시즈, 인코포레이티드 |
Inhibitors of flaviviridae viruses
|
PL2477987T3
(en)
|
2009-09-14 |
2018-06-29 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors
|
ME02656B
(en)
|
2009-09-21 |
2017-06-20 |
Gilead Sciences Inc |
2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8962652B2
(en)
|
2009-10-22 |
2015-02-24 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
US20110150836A1
(en)
|
2009-12-22 |
2011-06-23 |
Gilead Sciences, Inc. |
Methods of treating hbv and hcv infection
|
JP5777223B2
(en)
|
2010-01-15 |
2015-09-09 |
ギリアード サイエンシーズ, インコーポレイテッド |
Inhibitors of Flaviviridae virus
|
AP3576A
(en)
|
2010-01-15 |
2016-02-08 |
Gilead Sciences Inc |
Inhibitors of flaviviridae viruses
|
BR112012015951A2
(en)
|
2010-01-28 |
2018-10-16 |
Hoffmann La Roche |
4 azido nucleosides as anti-hcv compounds
|
US20110223131A1
(en)
|
2010-02-24 |
2011-09-15 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CA2796826A1
(en)
|
2010-05-10 |
2011-11-17 |
Gilead Sciences, Inc. |
Bifunctional quinoline derivatives
|
US8367829B2
(en)
|
2010-05-10 |
2013-02-05 |
Gilead Sciences, Inc. |
Bi-functional pyrazolopyridine compounds
|
EP2571882A1
(en)
|
2010-05-21 |
2013-03-27 |
Gilead Sciences, Inc. |
Heterocyclic flaviviridae virus inhibitors
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
TW201210597A
(en)
|
2010-06-09 |
2012-03-16 |
Gilead Sciences Inc |
Inhibitors of hepatitis C virus
|
TW201211047A
(en)
|
2010-06-10 |
2012-03-16 |
Gilead Sciences Inc |
Methods for treating HCV
|
NZ604037A
(en)
|
2010-06-11 |
2014-11-28 |
Gilead Sciences Inc |
Topical antiviral formulations for prevention of transmission of hsv-2
|
RS54761B1
(en)
|
2010-06-24 |
2016-10-31 |
Gilead Sciences |
Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents
|
JP5984218B2
(en)
|
2010-07-02 |
2016-09-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
Naphtho-2-ylacetic acid derivatives for treating AIDS
|
WO2012003498A1
(en)
|
2010-07-02 |
2012-01-05 |
Gilead Sciences, Inc. |
2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
|
KR20200052384A
(en)
|
2010-07-19 |
2020-05-14 |
길리애드 사이언시즈, 인코포레이티드 |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
ES2524356T3
(en)
|
2010-07-22 |
2014-12-05 |
Gilead Sciences, Inc. |
Methods and compounds to treat infections caused by Paramyxoviridae virus
|
CN102351931B
(en)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
Pyrimidine nucleoside derivatives as well as synthesis method and application thereof in preparation of anti-tumor and antiviral drugs
|
TW201305185A
(en)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
CA2807496C
(en)
|
2010-09-20 |
2019-01-22 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
KR101835474B1
(en)
|
2010-11-17 |
2018-03-08 |
길리애드 파마셋 엘엘씨 |
Antiviral compounds
|
CN106511357A
(en)
|
2010-11-19 |
2017-03-22 |
吉利德科学公司 |
Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate
|
UY33775A
(en)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND THEIR USES
|
NZ613370A
(en)
|
2010-12-20 |
2015-05-29 |
Gilead Sciences Inc |
Combinations for treating hcv
|
US20130280212A1
(en)
|
2010-12-21 |
2013-10-24 |
Gilead Sciences, Inc |
Inhibitors of cytochrome p450
|
US8987313B2
(en)
|
2010-12-21 |
2015-03-24 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome P450
|
WO2012088178A1
(en)
|
2010-12-21 |
2012-06-28 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome p450 (cyp3a4)
|
AU2012240314A1
(en)
|
2011-04-04 |
2013-05-02 |
Gilead Sciences, Inc. |
Process for the preparation of an HIV integrase inhibitor
|
JP2014510139A
(en)
|
2011-04-04 |
2014-04-24 |
ギリアード サイエンシーズ, インコーポレイテッド |
HIV inhibitor in solid form
|
AU2012242517B2
(en)
|
2011-04-13 |
2016-12-15 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
KR20140027295A
(en)
|
2011-04-21 |
2014-03-06 |
길리애드 사이언시즈, 인코포레이티드 |
Benzothiazole compounds and their pharmaceutical use
|
US20140187771A1
(en)
|
2011-05-02 |
2014-07-03 |
Gilead Sciences, Inc. |
Amorphous solid salts
|
WO2013006738A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
CN103687868A
(en)
|
2011-07-06 |
2014-03-26 |
吉利德科学股份有限公司 |
Hcv genotype 4 replicons
|
US8889848B2
(en)
|
2011-07-06 |
2014-11-18 |
Gilead Sciences, Inc. |
HCV genotype 3 replicons
|
WO2013010112A1
(en)
|
2011-07-13 |
2013-01-17 |
Gilead Sciences, Inc. |
Thiophen-2-carboxylic acid derivatives useful as inhibitors of flaviviridae viruses
|
UY34262A
(en)
|
2011-08-16 |
2013-04-05 |
Gilead Sciences Inc |
TENOFOVIR ALAFENAMIDE HEMIFUMARATE, ITS COMPOSITIONS, PREPARATION METHOD, METHODS TO TREAT VIRAL INFECTIONS AND ITS USE TO PREPARE MEDI CAMENTS
|
SI2709613T2
(en)
|
2011-09-16 |
2020-12-31 |
Gilead Pharmasset LLC c/o Gilead Sciences, Inc. |
Methods for treating hcv
|
AU2012332827A1
(en)
|
2011-10-31 |
2014-05-15 |
Gilead Pharmasset Llc |
Methods and compositions for treating hepatitis C virus
|
SI2907816T1
(en)
|
2011-11-16 |
2018-10-30 |
Gilead Pharmasset Llc |
Condensed imidazolylimidazoles as antiviral compounds
|
AU2012346217B2
(en)
|
2011-11-29 |
2016-02-04 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
WO2013090929A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
Amino quinoline derivatives inhibitors of hcv
|
WO2013090840A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors
|
EP2793891A1
(en)
|
2011-12-20 |
2014-10-29 |
Gilead Sciences, Inc. |
Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders
|
WO2013096681A1
(en)
|
2011-12-22 |
2013-06-27 |
Gilead Sciences, Inc. |
Pyrazolo[1,5-a]pyrimidines as antiviral agents
|
AU2013235220C1
(en)
|
2011-12-22 |
2019-03-28 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9073960B2
(en)
|
2011-12-22 |
2015-07-07 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013103724A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
|
US9284323B2
(en)
|
2012-01-04 |
2016-03-15 |
Gilead Sciences, Inc. |
Naphthalene acetic acid derivatives against HIV infection
|
US20150004239A1
(en)
|
2012-01-12 |
2015-01-01 |
Gilead Sciences, Inc. |
Pharmaceutical compositions and methods for their preparation
|
CN104105484A
(en)
|
2012-02-03 |
2014-10-15 |
吉联亚科学公司 |
Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
|
AU2012327170A1
(en)
|
2012-02-03 |
2013-08-22 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
NZ629996A
(en)
|
2012-03-13 |
2016-10-28 |
Gilead Sciences Inc |
2’- substituted carba-nucleoside analogs for antiviral treatment
|
LT2838900T
(en)
|
2012-04-17 |
2019-11-11 |
Gilead Sciences Inc |
Compounds and methods for antiviral treatment
|
PE20141558A1
(en)
|
2012-04-20 |
2014-11-06 |
Gilead Sciences Inc |
DERIVATIVES OF BENZOTHIAZOLE-6-IL ACETIC ACID AND THEIR USE TO TREAT HIV INFECTION
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
PT2859009T
(en)
|
2012-06-08 |
2018-01-18 |
Gilead Sciences Inc |
Macrocyclic inhibitors of flaviviridae viruses
|
KR20150040265A
(en)
|
2012-06-08 |
2015-04-14 |
길리애드 사이언시즈, 인코포레이티드 |
Macrocyclic inhibitors of flaviviridae viruses
|
AR091279A1
(en)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE
|
UA119315C2
(en)
|
2012-07-03 |
2019-06-10 |
Гіліад Фармассет Елелсі |
Inhibitors of hepatitis c virus
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
US20140094485A1
(en)
|
2012-10-03 |
2014-04-03 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor
|
CN104755995B
(en)
|
2012-10-26 |
2017-10-24 |
皇家飞利浦有限公司 |
Auto-stereoscopic display device with transparent operation pattern
|
JP2015535261A
(en)
*
|
2012-10-29 |
2015-12-10 |
コクリスタル ファーマ,インコーポレイテッド |
Pyrimidine nucleotides and their monophosphate prodrugs for the treatment of viral infections and cancer
|
CN107982531A
(en)
|
2012-10-30 |
2018-05-04 |
吉利德科学公司 |
Treatment relevant with lysyloxidase sample albumen 2 (LOXL2) and diagnostic method
|
EP2917340A1
(en)
|
2012-11-07 |
2015-09-16 |
Gilead Sciences, Inc. |
Hcv genotype 6 replicons
|
EP2935304A1
(en)
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
UY35213A
(en)
|
2012-12-21 |
2014-06-30 |
Gilead Sciences Inc |
COMPOUNDS OF THE TYPE OF POLYCYCLIC CARBAMYLPIRIDONS AND THEIR PHARMACEUTICAL USE
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
RS61767B1
(en)
|
2012-12-21 |
2021-05-31 |
Janssen Biopharma Inc |
4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv
|
TW201443037A
(en)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
Therapeutic compounds
|
PT2943487T
(en)
|
2013-01-09 |
2016-12-15 |
Gilead Sciences Inc |
5-membered heteroaryls and their use as antiviral agents
|
EP2943493B1
(en)
|
2013-01-09 |
2017-08-02 |
Gilead Sciences, Inc. |
Therapeutic compounds for the treatment of viral infections
|
WO2014124430A1
(en)
|
2013-02-11 |
2014-08-14 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
TWI694071B
(en)
|
2013-03-01 |
2020-05-21 |
美商基利科學股份有限公司 |
Therapeutic compounds for treating a retroviridae viral infection
|
US20140273023A1
(en)
|
2013-03-15 |
2014-09-18 |
Saladax Biomedical Inc. |
Gemcitabine immunoassay
|
BR112015021768A2
(en)
|
2013-03-15 |
2016-02-02 |
Gilead Sciences Inc |
hepatitis c virus inhibitors
|
WO2014165542A1
(en)
|
2013-04-01 |
2014-10-09 |
Idenix Pharmaceuticals, Inc. |
2',4'-fluoro nucleosides for the treatment of hcv
|
WO2014169280A2
(en)
|
2013-04-12 |
2014-10-16 |
Achillion Pharmaceuticals, Inc. |
Deuterated nucleoside prodrugs useful for treating hcv
|
AU2014265293B2
(en)
|
2013-05-16 |
2019-07-18 |
Riboscience Llc |
4'-Fluoro-2'-methyl substituted nucleoside derivatives
|
ES2952714T3
(en)
|
2013-06-26 |
2023-11-03 |
Janssen Pharmaceuticals Inc |
Substituted nucleosides, nucleotides and analogues thereof
|
US20150072418A1
(en)
|
2013-08-16 |
2015-03-12 |
Gilead Sciences, Inc. |
Hcv genotype 4d replicons
|
SI3043803T1
(en)
|
2013-09-11 |
2022-09-30 |
Emory University |
Nucleotide and nucleoside compositions and their uses
|
SG10201804835VA
(en)
|
2013-10-11 |
2018-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
UA119050C2
(en)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections
|
WO2015084741A2
(en)
|
2013-12-02 |
2015-06-11 |
Gilead Pharmasset Llc |
Methods of treating hepatitis c virus infection in subjects with cirrhosis
|
TW201609785A
(en)
|
2013-12-23 |
2016-03-16 |
吉李德製藥公司 |
Solid forms of an antiviral compound
|
ES2708993T3
(en)
|
2013-12-23 |
2019-04-12 |
Gilead Sciences Inc |
Crystalline forms of an NS3 NS3 inhibitor macrocyclic tripeptide
|
TWI660965B
(en)
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
Solid forms of tenofovir
|
EP3094323A4
(en)
|
2014-01-17 |
2017-10-11 |
Ligand Pharmaceuticals Incorporated |
Methods and compositions for modulating hormone levels
|
US9463194B2
(en)
|
2014-02-05 |
2016-10-11 |
Gilead Sciences, Inc. |
Methods of treating patients co-infected with HIV and tuberculosis
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
WO2015130966A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Antiviral agents
|
WO2015179448A1
(en)
|
2014-05-21 |
2015-11-26 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
ES2686352T3
(en)
|
2014-06-12 |
2018-10-17 |
Gilead Sciences, Inc. |
Antiviral compounds
|
EP3154960A1
(en)
|
2014-06-13 |
2017-04-19 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
WO2015191754A2
(en)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
WO2015191743A1
(en)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences, Inc. |
Quinazolinone derivatives as phosphatidylinositol 3-kinase inhibitors
|
MX2016016528A
(en)
|
2014-06-13 |
2017-03-27 |
Gilead Sciences Inc |
Phosphatidylinositol 3-kinase inhibitors.
|
MX2016016516A
(en)
|
2014-06-13 |
2017-05-01 |
Gilead Sciences Inc |
Phosphatidylinositol 3-kinase inhibitors.
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
HUE051986T2
(en)
|
2014-06-24 |
2021-04-28 |
Janssen Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof for use in the treatment of viral infection
|
TN2016000566A1
(en)
|
2014-06-24 |
2018-04-04 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
CN105288635A
(en)
|
2014-06-26 |
2016-02-03 |
昆明积大制药股份有限公司 |
Pharmaceutical composition containing 5'-Ara-C-O-amino ester
|
MX2017000026A
(en)
|
2014-07-11 |
2017-05-01 |
Gilead Sciences Inc |
Modulators of toll-like receptors for the treatment of hiv.
|
TWI678369B
(en)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
|
TWI673283B
(en)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2'-chloro aminopyrimidinone and pyrimidine dione nucleosides
|
NZ729150A
(en)
|
2014-08-29 |
2018-02-23 |
Gilead Sciences Inc |
Antiretroviral agents
|
US20160067255A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
EP3034499A1
(en)
|
2014-12-17 |
2016-06-22 |
Gilead Sciences, Inc. |
Novel FXR (NR1H4) modulating compounds
|
TWI738321B
(en)
|
2014-12-23 |
2021-09-01 |
美商基利科學股份有限公司 |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
PT3237397T
(en)
|
2014-12-24 |
2019-02-08 |
Gilead Sciences Inc |
Isoquinoline compounds for the treatment of hiv
|
MX2017008520A
(en)
|
2014-12-24 |
2018-03-01 |
Gilead Sciences Inc |
Fused pyrimidine compounds for the treatment of hiv.
|
TWI770552B
(en)
|
2014-12-24 |
2022-07-11 |
美商基利科學股份有限公司 |
Quinazoline compounds
|
RS62434B1
(en)
|
2014-12-26 |
2021-11-30 |
Univ Emory |
Anti-viral n4-hydroxycytidine derivatives
|
WO2016134054A1
(en)
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Anti-viral compounds
|
SI3097102T1
(en)
|
2015-03-04 |
2018-02-28 |
Gilead Sciences, Inc. |
Toll-like receptor modulating 4,6-diamino-pyrido(3,2-d)pyrimidine compounds
|
NZ735575A
(en)
|
2015-04-02 |
2018-11-30 |
Gilead Sciences Inc |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
JP2018511621A
(en)
|
2015-04-14 |
2018-04-26 |
ギリアード サイエンシーズ, インコーポレイテッド |
Method for treating hepatitis B virus
|
WO2016186967A1
(en)
|
2015-05-15 |
2016-11-24 |
Gilead Sciences, Inc. |
Benzimidazole and imadazopyridine carboximidamide compounds having activity as inhibitors of indoleamine 2,3-dioxygenase
|
EP4092037A1
(en)
|
2015-06-17 |
2022-11-23 |
Gilead Sciences, Inc. |
Co-crystals, salts and solid forms of tenofovir alafenamide
|
PT4070788T
(en)
|
2015-06-30 |
2023-06-06 |
Gilead Sciences Inc |
Pharmaceutical formulations
|
CA2921336A1
(en)
|
2015-06-30 |
2016-12-30 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
MX2018001073A
(en)
|
2015-08-06 |
2018-06-12 |
Chimerix Inc |
Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents.
|
CA2995004A1
(en)
|
2015-08-26 |
2017-03-02 |
Gilead Sciences, Inc. |
Deuterated toll-like receptor modulators
|
WO2017040895A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral compounds
|
WO2017040896A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral compounds
|
CA2997955A1
(en)
|
2015-09-15 |
2017-03-23 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
HUE058737T2
(en)
|
2015-09-16 |
2022-09-28 |
Gilead Sciences Inc |
Methods for treating arenaviridae virus infections
|
NZ741785A
(en)
|
2015-09-30 |
2019-07-26 |
Gilead Sciences Inc |
3-cyano-1h-1,2,4-triazol-1-yl compounds and uses thereof for the treatment of hiv
|
JP2018530550A
(en)
|
2015-10-01 |
2018-10-18 |
ギリアド サイエンシズ, インコーポレイテッド |
Combination of BTK inhibitor and checkpoint inhibitor for the treatment of cancer
|
JP6621933B2
(en)
|
2015-11-09 |
2019-12-18 |
ギリアード サイエンシス インコーポレーテッド |
Therapeutic composition for treating human immunodeficiency virus
|
KR102165120B1
(en)
|
2015-12-15 |
2020-10-13 |
길리애드 사이언시즈, 인코포레이티드 |
Human immunodeficiency virus neutralizing antibodies
|
CR20180320A
(en)
|
2015-12-17 |
2018-08-21 |
Gilead Sciences Inc |
INHIBITING COMPOUNDS OF QUINASA DE UNION A TANK
|
US10874683B2
(en)
|
2016-03-10 |
2020-12-29 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
US11963972B2
(en)
*
|
2016-03-23 |
2024-04-23 |
Emory University |
Antiviral agents and nucleoside analogs for treatment of Zika virus
|
EP3712273A1
(en)
|
2016-04-08 |
2020-09-23 |
Krystal Biotech, LLC |
Compositions for the treatment of wounds, disorders, and diseases of the skin
|
WO2017184668A1
(en)
|
2016-04-20 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating flaviviridae virus infections
|
WO2017184670A2
(en)
|
2016-04-22 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating zika virus infections
|
EP3463469B1
(en)
|
2016-05-27 |
2023-12-13 |
Gilead Sciences, Inc. |
Combination of ledipasvir and sofosbuvir for use in the treatment of hepatitis b virus infections in humans
|
BR102017010009A2
(en)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
COMPOUNDS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION
|
EP3471738A4
(en)
|
2016-06-20 |
2020-01-01 |
Merck Sharp & Dohme Corp. |
Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2017223268A1
(en)
|
2016-06-22 |
2017-12-28 |
Yale University |
COMPOSITIONS AND METHODS OF RESENSITIZING CELLS TO BROMODOMAIN AND EXTRATERMINAL DOMAIN PROTEIN INHIBITORS (BETi)
|
KR102626210B1
(en)
*
|
2017-12-07 |
2024-01-18 |
에모리 유니버시티 |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
WO2019173602A1
(en)
|
2018-03-07 |
2019-09-12 |
Emory University |
4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto
|
PE20230466A1
(en)
|
2020-02-07 |
2023-03-14 |
Univ Emory |
N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTIVIRAL USES RELATED THERETO
|